Lehnert Adrienne L, Miyaoka Robert S
Department of Radiology, University of Washington, 1959 Northeast Pacific Street, UW Box 356043, Seattle, WA, USA.
Department of Radiology, University of Washington, 1959 Northeast Pacific Street, UW Box 356043, Seattle, WA, USA.
PET Clin. 2024 Jan;19(1):59-67. doi: 10.1016/j.cpet.2023.09.002. Epub 2023 Sep 27.
Biomedical research has long relied on small-animal studies to elucidate disease process and develop new medical treatments. The introduction of in vivo functional imaging technology, such as PET, has allowed investigators to peer inside their subjects and follow disease progression longitudinally as well as improve understanding of normal biological processes. Recent developments in CRISPR, immuno-PET, and high-resolution in vivo imaging have only increased the importance of small-animal, or preclinical, PET imaging. Other drivers of preclinical PET innovation include new combinations of imaging technologies, such as PET/MR imaging, which require changes to PET hardware.
长期以来,生物医学研究一直依赖于小动物研究来阐明疾病过程并开发新的医学治疗方法。正电子发射断层扫描(PET)等体内功能成像技术的引入,使研究人员能够深入观察研究对象,并纵向跟踪疾病进展,同时增进对正常生物过程的理解。成簇规律间隔短回文重复序列(CRISPR)、免疫PET和高分辨率体内成像的最新进展,只会增加小动物或临床前PET成像的重要性。临床前PET创新的其他推动因素包括成像技术的新组合,如PET/磁共振成像(MR),这需要对PET硬件进行改进。